Expert Opinion on Emerging Drugs

Emerging drugs for hepatitis C
pp. 1-19(19)
Authors: Soriano, Vincent; Madejon, Antonio; Vispo, Eugenia; Labarga, Pablo; Garcia-Samaniego, Javier; Martin-Carbonero, Luz; Sheldon, Julie; Bottecchia, Marcelle; Tuma, Paula; Barreiro, Pablo

Emerging vaccines for influenza
pp. 21-40(20)
Authors: Tosh, Pritish K; Poland, Gregory A

The potential impact of a prophylactic herpes simplex vaccine
pp. 41-52(12)
Authors: Rupp, Richard; Bernstein, David I

Emerging therapies for fibromyalgia
pp. 53-62(10)
Authors: Ablin, Jacob N; Buskila, Dan

Emerging drugs for spinal cord injury
pp. 63-80(18)
Authors: Baptiste, Darryl C; Fehlings, Michael G

Emerging drugs for malignant glioma
pp. 81-94(14)
Author: Mason, Warren P

Emerging drugs for rarer chronic lymphoid leukemias
pp. 95-118(24)
Author: Robak, Tadeusz

Uterine myoma: a condition amendable to medical therapy?
pp. 119-133(15)
Authors: Cheng, Ming-Huei; Wang, Peng-Hui

Emerging drugs in the treatment of advanced gastric cancer
pp. 135-144(10)
Authors: Tetzlaff, Eric D; Cen, Putao; Ajani, Jaffer A

Emerging drugs for non-alcoholic fatty liver disease
pp. 145-158(14)
Authors: Federico, Alessandro; Niosi, Marco; Vecchio Blanco, Camillo Del; Loguercio, Carmela

Emerging drugs for complications of end-stage liver disease
pp. 159-174(16)
Authors: Dowman, Joanna K; Holt, Andrew P; Newsome, Philip N; Adams, David H

Emerging drugs for rheumatoid arthritis
pp. 175-196(22)
Author: Voulgari, Paraskevi V

Treatment perspectives for the lysosomal storage diseases
pp. 197-211(15)
Author: Grabowski, Gregory A